<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - BETAMETHASONE</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>BETAMETHASONE</h1>

        <p><a href="../drugClass/PHP34623.html">CORTICOSTEROIDS (SYSTEMIC)</a><a href="../drugClass/PHP34550.html">CORTICOSTEROIDS (TOPICAL)</a><a href="../drugClass/PHP34648.html">CORTICOSTEROIDS (INTRANASAL)</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#professionSpecificInformation" data-toggle="tab">Profession specific information</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Local treatment of inflammation (short term)</span>,
            </h4>
            <p class="specificity"><span class="route">To the eye using eye ointment</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply every 1&#8211;2 hours until controlled then reduce frequency.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply 2&#8211;4 times a day, alternatively apply at night when used in combination with eye drops.</li>
              <li class="dose child"><strong>For children </strong><br/>
                Apply every 1&#8211;2 hours until controlled then reduce frequency.</li>
              <li class="dose child"><strong>For children </strong><br/>
                Apply 2&#8211;4 times a day, alternatively apply at night when used in combination with eye drops.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids</span>,
                <span class="indication">Psoriasis</span>,
            </h4>
            <p class="specificity"><span class="route">To the skin</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply 1&#8211;2 times a day, to be applied thinly.</li>
              <li class="dose child"><strong>For children </strong><br/>
                Apply 1&#8211;2 times a day, to be applied thinly.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Suppression of inflammatory and allergic disorders</span>,
                <span class="indication">Congenital adrenal hyperplasia</span>,
            </h4>
            <p class="specificity"><span class="route">By intramuscular injection or by slow intravenous injection or by intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Usual dose 0.5&#8211;5 mg daily.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                4&#8211;20 mg, repeated up to 4 times in 24 hours.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Oral ulceration</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth using soluble tablets</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 micrograms 4 times a day, to be dissolved in 20 mL water and rinsed around the mouth; not to be swallowed.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                500 micrograms 4 times a day, to be dissolved in 20 mL water and rinsed around the mouth; not to be swallowed.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
            <section class="potency">
              <h3>Potency of preperations</h3>
              <p>Betamethasone valerate 0.025% cream and ointment: moderate.</p><p>Betamethasone valerate 0.1% cream, lotion, medicated plasters, ointment, and scalp application: potent.</p><p>Betamethasone valerate 0.12% foam: potent.</p><p>Betamethasone dipropionate 0.05% cream, lotion, and ointment: potent.</p>
            </section>
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>Readily crosses the placenta.</p><p>Transient effect on fetal movements and heart rate.</p>
            </section>
      </section>



      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>notKnown:</strong> local sensitivity reactions, adrenal suppression following prolonged use in neonates in neonates, corneal thinning, scleral thinning, candidal infection, exacerbation of local infection,
              </p>
        
        
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in children</h3>
              <p>For <i>intravenous infusion</i>, dilute with Glucose 5% or Sodium Chloride 0.9%.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in adults</h3>
              <p>For <i>intravenous infusion</i> (as sodium phosphate) (<i>Betnesol</i>
            <tm tmtype="reg"/>), give continuously or intermittently <i>or via</i> drip tubing <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%.</p>
            </section>
      </section>

      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="generalPatientAdvice">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in adults</h3>
              <p>Patient counselling is advised for betamethasone soluble tablets (steroid card).</p>
            </section>
            <section class="generalPatientAdvice">
              <h3 class="specificity">With <ph outputclass="route">oral (topical)</ph> use</h3>
              <p>Patient counselling is advised for betamethasone soluble tablets (administration).</p>
            </section>
            <section class="generalPatientAdvice">
              <h3 class="specificity">With <ph outputclass="route">topical</ph> use</h3>
              <p>Patient counselling is advised for betamethasone cream, ointment, scalp application and foam (application).</p>
            </section>
      </section>



      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>When used by ear:</strong>
            avoid prolonged use
          </li>
          <li>
              <strong>With topical use:</strong>
            use of more than 100&#8239;g per week of 0.1% preparation likely to cause adrenal suppression
          </li>
        </ul>
      </section>



      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">oral (topical)</ph> use in children</h3>
              <p>Betamethasone soluble tablets not licensed for use as mouthwash or in oral ulceration.</p>
            </section>
            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">topical</ph> use in children</h3>
              <p>
            <i>Betacap</i>
            <sup>
            <tm tmtype="reg"/>
            </sup>, <i>Betnovate</i>
            <sup>
            <tm tmtype="reg"/>
            </sup> and <i>Betnovate-RD</i>
            <sup>
            <tm tmtype="reg"/>
            </sup> are not licensed for use in children under 1 year.</p><p>
            <i>Bettamousse</i>
            <sup>
            <tm tmtype="reg"/>
            </sup> is not licensed for use in children under 6 years.</p>
            </section>
            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">intranasal</ph> use or when used by <ph outputclass="route">ear</ph> in children</h3>
              <p>Licensed for use in children (age range not specified by manufacturers).</p>
            </section>
      </section>







      <section class="tab-pane" id="professionSpecificInformation">
        <h2>Profession specific information</h2>

          <h3>Dental practitioners</h3>
        
            <section class="dentalPractitionersFormulary">
              <h3 class="specificity">With <ph outputclass="route">oral (topical)</ph> use</h3>
              <p>Betamethasone Soluble Tablets 500&#8239;micrograms may be prescribed for oral ulceration.</p>
            </section>
      </section>



      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of BETAMETHASONE</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            cream,
            ointment,

            <div id="PHP75745"><a href="../medicinalForm/PHP75745.html" data-target="#PHP75745" data-action="load">Soluble tablet</a></div>
            <div id="PHP75770"><a href="../medicinalForm/PHP75770.html" data-target="#PHP75770" data-action="load">Solution for injection</a></div>
            <div id="PHP75731"><a href="../medicinalForm/PHP75731.html" data-target="#PHP75731" data-action="load">Ear/eye/nose drops solution</a></div>
            <div id="PHP75764"><a href="../medicinalForm/PHP75764.html" data-target="#PHP75764" data-action="load">Eye ointment</a></div>
            <div id="PHP75738"><a href="../medicinalForm/PHP75738.html" data-target="#PHP75738" data-action="load">Foam</a></div>
            <div id="PHP75777"><a href="../medicinalForm/PHP75777.html" data-target="#PHP75777" data-action="load">Liquid</a></div>
            <div id="PHP75784"><a href="../medicinalForm/PHP75784.html" data-target="#PHP75784" data-action="load">Cream</a></div>
            <div id="PHP75797"><a href="../medicinalForm/PHP75797.html" data-target="#PHP75797" data-action="load">Ointment</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
